BRAF mutations in acute leukemias [5]

Leukemia

Volumn 18, Issue 1, 2004, Pages 170-172

  Lee, J W ^a   Soung, Y H ^a   Park, W S ^a   Kim, S Y ^a   Nam, S W ^a   Min, W S ^a   Lee, J Y ^a   Yoo, N J ^a   Lee, S H ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; IMATINIB; RAF PROTEIN; RAS PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MONOCYTIC LEUKEMIA; B CELL LEUKEMIA; CANCER PATIENT; CANCER REGRESSION; CELL PROLIFERATION; DNA SEQUENCE; DRUG EFFICACY; EXON; GENE MUTATION; HEMATOPOIETIC CELL; HUMAN; LETTER; LEUKEMIA CELL; LEUKEMOGENESIS; MONOCYTIC LEUKEMIA; MUTATION RATE; MYELOMONOCYTIC LEUKEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; T CELL LEUKEMIA;

EID: 0742272051     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403201     Document Type: Letter

References (8)

1. Lee Jr JT, McCubrey JA. The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention. Leukemia 2002; 16: 486-507.
2. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-954.
3. Radich JP, Kopecky KJ, Willman CL, Weick J, Head D, Appelbaum F et al. N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance. Blood 1990; 76: 801-807.
4. McCubrey JA, Steelman LS, Hoyle PE, Blalock WL, Weinstein-Oppenheimer C, Franklin RA et al. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells. Leukemia 1998; 12: 1903-1929.
5. McCubrey JA, Lee JT, Steelman LS, Blalock WL, Moye PW, Chang F et al. Interactions between the PI3 K and Raf signaling pathways can result in the transformation of hematopoietic cells. Cancer Detect Prev 2001; 25: 375-393.
6. Moye PW, Blalock WL, Hoyle PE, Chang F, Franklin RA, Weinstein-Oppenheimer C et al. Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells. Leukemia 2000; 14: 1060-1079.
7. Smith ML, Snaddon J, Neat M, Cambal-Parrales M, Arch R, Lister TA et al. Mutation of BRAF is uncommon in AML FAB type M1 and M2. Leukemia 2003; 17: 274-275.
8. Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY et al. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene 1999; 18: 3754-3760.